Cargando…
A modified MethyLight assay predicts the clinical outcomes of anti‐epidermal growth factor receptor treatment in metastatic colorectal cancer
DNA methylation status correlates with clinical outcomes of anti‐epidermal growth factor receptor (EGFR) treatment. There is a strong need to develop a simple assay for measuring DNA methylation status for the clinical application of drug selection based on it. In this study, we collected data from...
Autores principales: | Ouchi, Kota, Takahashi, Shin, Okita, Akira, Sakamoto, Yasuhiro, Muto, Osamu, Amagai, Kenji, Okada, Takaho, Ohori, Hisatsugu, Shinozaki, Eiji, Ishioka, Chikashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898715/ https://www.ncbi.nlm.nih.gov/pubmed/34962023 http://dx.doi.org/10.1111/cas.15252 |
Ejemplares similares
-
Analysis of repetitive element DNA methylation by MethyLight
por: Weisenberger, Daniel J., et al.
Publicado: (2005) -
Establishment of the MethyLight Assay for Assessing Aging, Cigarette Smoking, and Alcohol Consumption
por: Endo, Kosuke, et al.
Publicado: (2015) -
DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight
por: Weisenberger, Daniel J., et al.
Publicado: (2008) -
Novel Multiplex MethyLight Protocol for Detection of DNA Methylation in Patient Tissues and Bodily Fluids
por: Olkhov-Mitsel, Ekaterina, et al.
Publicado: (2014) -
A 115-bp MethyLight assay for detection of p16 (CDKN2A) methylation as a diagnostic biomarker in human tissues
por: Zhou, Jing, et al.
Publicado: (2011)